News

Integris Achieves CMMC Level 2 Certification for Enhanced Security

Integris Achieves CMMC Level 2 Certification for Enhanced Security

Integris Achieves CMMC Level 2 Certification for Enhanced Security

National IT MSP joins elite group of CMMC certified providers, setting a new benchmark for proven compliance expertise

Integris, a national leader in future-ready managed services, has recently announced an important milestone by obtaining Cybersecurity Maturity Model Certification (CMMC) Level 2. This achievement further distinguishes Integris in a competitive landscape, showcasing its dedication to protecting sensitive information for government contracts and enhancing compliance for its clients.

The CMMC program, instituted by the U.S. Department of Defense, is a critical initiative requiring contractors to adhere to stringent cybersecurity standards to safeguard Controlled Unclassified Information (CUI) and Federal Contract Information (FCI). Achieving this level of certification ensures that Integris has implemented a comprehensive set of security practices necessary for effective management of sensitive data, which is essential for organizations engaged in DoD contracts.

Dr. Brian Luckey, Chief Information Officer at Integris, remarked, "Passing this certification ourselves is a game changer for our clients. While many MSPs can guide you through compliance, having a partner who has successfully undergone the Level 2 audit offers invaluable insight into what evidence auditors require and how to create a sustainable, defensible posture. Clients will enjoy access to tried-and-tested methodologies, audit-ready documentation, and operational frameworks that withstand real-world scrutiny."

The Comprehensive Approach to CMMC Compliance

Integris embraces a holistic, three-pronged approach to assisting clients in achieving CMMC certification. This approach encompasses a range of managed services specifically designed for resilience and compliance, empowering organizations to successfully navigate CMMC standards over time.

CMMC Managed Services

Integris offers a suite of CMMC Managed Services tailored to boost preparedness. This includes readiness assessments, gap analyses, remediation planning, and hands-on support that ensures clients are equipped to handle compliance challenges effectively.

Managed Security Services

With a focus on security, Integris provides Managed Security Services that feature continuous monitoring, threat detection, timely incident response, and proactive vulnerability management. This keeps organizations informed and protected against emerging cybersecurity threats.

Managed Cloud Services

The company also excels in delivering Managed Cloud Services, creating secure and compliant cloud infrastructures tailored specifically for defense contractors. This service optimizes their operations while ensuring adherence to regulatory requirements.

As the demand for CMMC compliance rises within the realm of defense contracting, organizations dealing with CUI will find that securing a Level 2 certification is crucial to maintain competitiveness in acquiring contracts. Compliance is no longer merely a one-time achievement; it has evolved into an ongoing operational model that necessitates continuous attention and evidence of readiness.

Integris' successful certification allows the company to expedite its clients' paths to compliance while providing them with the confidence needed to seize new opportunities in the defense industry.

Why Choosing Integris Matters

By aligning with Integris, clients benefit from a relationship with a service provider that operates from experience and expertise gained from passing rigors of the CMMC certification process. The company arms businesses with not just theoretical knowledge but practical insight crucial for real-world compliance scenarios.

Frequently Asked Questions

What is CMMC Level 2 Certification?

CMMC Level 2 Certification signifies that a company has met a set of cybersecurity standards required to protect sensitive information, specifically for DoD contracts.

Why is CMMC important for businesses?

CMMC is vital as it ensures that contractors manage and protect sensitive data, which is essential for maintaining eligibility for defense contracts.

How can Integris help with CMMC compliance?

Integris provides tailored services including managed security and cloud services, readiness assessments, and continuous support to navigate CMMC requirements.

What are the main steps toward obtaining CMMC certification?

The main steps include conducting readiness assessments, remediation planning, implementing cybersecurity practices, and preparing for official audits.

How does Integris maintain its compliance expertise?

Integris maintains its compliance expertise through practical experience and its proactive approach to cybersecurity and regulatory standards across its services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading